{"id":"NCT01440946","sponsor":"Bioverativ Therapeutics Inc.","briefTitle":"Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B","officialTitle":"An Open-label, Multicenter Evaluation of Safety, Pharmacokinetics and Efficacy of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia B","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-06","primaryCompletion":"2014-11","completion":"2014-11","firstPosted":"2011-09-27","resultsPosted":"2015-06-18","lastUpdate":"2020-12-19"},"enrollment":30,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia B"],"interventions":[{"type":"DRUG","name":"rFIXFc","otherNames":["BIIB029","recombinant coagulation factor IX Fc fusion protein","AlprolixÂ®"]},{"type":"DRUG","name":"FIX","otherNames":["Factor IX"]}],"arms":[{"label":"rFIXFc Prophylaxis","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study is to evaluate the safety of Recombinant Human Coagulation Factor IX Fc Fusion Protein (rFIXFc) in previously treated pediatric subjects with hemophilia B. Secondary objectives of this study in this study population are as follows: to evaluate the efficacy of rFIXFc for prevention and treatment of bleeding episodes; to evaluate and assess the pharmacokinetics (PK) of rFIXFc; to evaluate rFIXFc consumption for prevention and treatment of bleeding episodes","primaryOutcome":{"measure":"Occurence of Factor IX (FIX) Inhibitor Development","timeFrame":"Up to 50 weeks +/- 7 days, or up to 50 EDs if reached prior to Week 50","effectByArm":[{"arm":"Participants < 6 Years Old","deltaMin":0,"sd":null},{"arm":"Participants 6 to < 12 Years Old","deltaMin":0,"sd":null},{"arm":"Total","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"MALE","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":2},"locations":{"siteCount":15,"countries":["United States","Australia","Ireland","Netherlands","South Africa","United Kingdom"]},"refs":{"pmids":["36848635","28159192"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":15},"commonTop":["Nasopharyngitis","Pyrexia","Viral Infection","Fall","Face Injury"]}}